Menard Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Buy |
7,949
+341
| +4% | +$63.3K | 0.88% | 24 |
|
|
2025
Q1 | $1.42M | Buy |
7,608
+822
| +12% | +$154K | 0.93% | 26 |
|
|
2024
Q4 | $1.21M | Buy |
6,786
+518
| +8% | +$92K | 0.72% | 29 |
|
|
2024
Q3 | $1.24M | Sell |
6,268
-186
| -3% | -$36.7K | 0.82% | 27 |
|
|
2024
Q2 | $1.11M | Buy |
6,454
+1,724
| +36% | +$296K | 0.79% | 26 |
|
|
2024
Q1 | $861K | Buy |
4,730
+2,885
| +156% | +$525K | 0.72% | 31 |
|
|
2023
Q4 | $286K | Buy |
1,845
+137
| +8% | +$21.2K | 0.36% | 60 |
|
|
2023
Q3 | $255K | Sell |
1,708
-302
| -15% | -$45K | 0.37% | 63 |
|
|
2023
Q2 | $271K | Buy |
2,010
+389
| +24% | +$52.4K | 0.56% | 45 |
|
|
2023
Q1 | $258K | Hold |
1,621
| – | – | 0.6% | 46 |
|
|
2022
Q4 | $262K | Hold |
1,621
| – | – | 0.62% | 48 |
|
|
2022
Q3 | $218K | Sell |
1,621
-45
| -3% | -$6.05K | 0.39% | 74 |
|
|
2022
Q2 | $255K | Sell |
1,666
-655
| -28% | -$100K | 0.42% | 69 |
|
|
2022
Q1 | $376K | Sell |
2,321
-23
| -1% | -$3.73K | 0.37% | 87 |
|
|
2021
Q4 | $317K | Sell |
2,344
-274
| -10% | -$37.1K | 0.26% | 107 |
|
|
2021
Q3 | $282K | Sell |
2,618
-14
| -0.5% | -$1.51K | 0.25% | 118 |
|
|
2021
Q2 | $296K | Buy |
2,632
+96
| +4% | +$10.8K | 0.28% | 106 |
|
|
2021
Q1 | $274K | Buy |
2,536
+47
| +2% | +$5.08K | 0.29% | 110 |
|
|
2020
Q4 | $267K | Buy |
+2,489
| New | +$267K | 0.29% | 111 |
|
|
2020
Q3 | – | Sell |
-2,331
| Closed | -$229K | – | 139 |
|
|
2020
Q2 | $229K | Buy |
+2,331
| New | +$229K | 0.29% | 93 |
|
|
2020
Q1 | – | Sell |
-3,763
| Closed | -$333K | – | 22 |
|
|
2019
Q4 | $333K | Buy |
+3,763
| New | +$333K | 0.32% | 100 |
|